HealthX is excited to offer grants for teams of students who are developing innovative ideas in healthcare. The HealthX Venture Fund is a student run fund that aims to financially support Penn students seeking to fill a need in our healthcare system. This funding takes the form of a grant and not an investment, and so teams will have complete ownership of their idea—no equity or loan is involved. Teams can receive up to $5,000 in funding in order to develop their ideas and applications are accepted on a rolling basis. Past HealthX backed companies include Oncora and Stetho.
Teams must first complete a written application about their startup. Applications are reviewed on a rolling basis. From this pool of applicants, finalists will be chosen to receive an initial $1,000 to develop their ideas. While we are open to a broad-spectrum of ideas, we will give preference to startups that meet a technology demand gap in the current healthcare landscape. After a period of development, the team will pitch their ideas.
When teams are ready, they will pitch their idea to a committee comprising of HealthX board members and advisors. Pitches last for 10 minutes and will be followed by 10 minutes of questions and answers. Teams that successfully pitch their ideas will receive another round of funding for $4,000 to carry forth their ideas.
Funded teams are expected to update HealthX on their progress and participate in the HealthX conference and other HealthX events. We also ask that start ups acknowledge that they have received funding from HealthX on their company website and other press materials.
SpectrumScores will empowerLGBTQ+ people to take back control of their health by offering an intuitive ranking andreview system for healthcare providers based on their LGBT-competence and friendliness.
Daedalus Diagnostic aims to provide a comprehensive medical diagnostic platform that leverages the inherent surveillance capabilities of circulating T cellsand the data encoded within their genomic architecture to rapidly, specifically, and cheaply test for disease.
Sanguis is a hand-held and inexpensive blood cell counting device that patients can use at home for frequent monitoring, unquestionably changing their lives for the better. http://sanguislab.com
Ostiio is developing a novel, fully internalized distractor for use in the craniofacial skeleton. With its magnetic activation mechanism, Ostiio’s distractor can be expanded wirelessly and with precision, across a patient’s skin.
AutoRad is seeking to disrupt the teleradiology market by creating software that triages non-contrast head CT scans based on level of urgency. They will use a machine learning approach to train our program to produce accurate, timely results.